US20230093881A1 - Hand sanitizer and method of making the same - Google Patents
Hand sanitizer and method of making the same Download PDFInfo
- Publication number
- US20230093881A1 US20230093881A1 US17/994,140 US202217994140A US2023093881A1 US 20230093881 A1 US20230093881 A1 US 20230093881A1 US 202217994140 A US202217994140 A US 202217994140A US 2023093881 A1 US2023093881 A1 US 2023093881A1
- Authority
- US
- United States
- Prior art keywords
- oil
- disinfecting
- vitamin
- hand
- sanitizer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 239000002775 capsule Substances 0.000 claims abstract description 132
- 230000000249 desinfective effect Effects 0.000 claims abstract description 118
- 229920000642 polymer Polymers 0.000 claims abstract description 79
- 239000006260 foam Substances 0.000 claims abstract description 75
- 239000003381 stabilizer Substances 0.000 claims abstract description 46
- 239000003205 fragrance Substances 0.000 claims abstract description 42
- 239000000645 desinfectant Substances 0.000 claims abstract description 36
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 22
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 18
- 239000004088 foaming agent Substances 0.000 claims abstract description 16
- 239000004599 antimicrobial Substances 0.000 claims abstract description 8
- 230000000153 supplemental effect Effects 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 85
- 239000000243 solution Substances 0.000 claims description 74
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 66
- 239000000725 suspension Substances 0.000 claims description 58
- 229920002873 Polyethylenimine Polymers 0.000 claims description 57
- 239000010678 thyme oil Substances 0.000 claims description 50
- 239000004615 ingredient Substances 0.000 claims description 43
- 238000002156 mixing Methods 0.000 claims description 40
- -1 triethyhexanoin Substances 0.000 claims description 34
- 229930003427 Vitamin E Natural products 0.000 claims description 33
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 33
- 235000019165 vitamin E Nutrition 0.000 claims description 33
- 229940046009 vitamin E Drugs 0.000 claims description 33
- 239000011709 vitamin E Substances 0.000 claims description 33
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 27
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims description 23
- 229920002413 Polyhexanide Polymers 0.000 claims description 23
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 20
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 16
- 229920001661 Chitosan Polymers 0.000 claims description 12
- 239000000341 volatile oil Substances 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 11
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 10
- 239000004264 Petrolatum Substances 0.000 claims description 10
- 229930003268 Vitamin C Natural products 0.000 claims description 10
- 229960005150 glycerol Drugs 0.000 claims description 10
- 229940066842 petrolatum Drugs 0.000 claims description 10
- 235000019271 petrolatum Nutrition 0.000 claims description 10
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 10
- 235000019154 vitamin C Nutrition 0.000 claims description 10
- 239000011718 vitamin C Substances 0.000 claims description 10
- 229960000541 cetyl alcohol Drugs 0.000 claims description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 8
- 239000003974 emollient agent Substances 0.000 claims description 8
- 229920002674 hyaluronan Polymers 0.000 claims description 8
- 229960003160 hyaluronic acid Drugs 0.000 claims description 8
- 229940088594 vitamin Drugs 0.000 claims description 8
- 229930003231 vitamin Natural products 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 8
- 239000011782 vitamin Substances 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 7
- 241000196324 Embryophyta Species 0.000 claims description 6
- 229920000289 Polyquaternium Polymers 0.000 claims description 6
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 6
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 6
- 229940106189 ceramide Drugs 0.000 claims description 6
- 150000001783 ceramides Chemical class 0.000 claims description 6
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 5
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 5
- 229920002498 Beta-glucan Polymers 0.000 claims description 5
- 239000004166 Lanolin Substances 0.000 claims description 5
- 239000004909 Moisturizer Substances 0.000 claims description 5
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 5
- 229940061720 alpha hydroxy acid Drugs 0.000 claims description 5
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims description 5
- 235000013871 bee wax Nutrition 0.000 claims description 5
- 239000012166 beeswax Substances 0.000 claims description 5
- 229940092738 beeswax Drugs 0.000 claims description 5
- 235000014121 butter Nutrition 0.000 claims description 5
- 229960003260 chlorhexidine Drugs 0.000 claims description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 5
- 229960001231 choline Drugs 0.000 claims description 5
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000010642 eucalyptus oil Substances 0.000 claims description 5
- 229940044949 eucalyptus oil Drugs 0.000 claims description 5
- 229940039717 lanolin Drugs 0.000 claims description 5
- 235000019388 lanolin Nutrition 0.000 claims description 5
- 239000002480 mineral oil Substances 0.000 claims description 5
- 235000010446 mineral oil Nutrition 0.000 claims description 5
- 230000001333 moisturizer Effects 0.000 claims description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 5
- 229940056211 paraffin Drugs 0.000 claims description 5
- 239000012188 paraffin wax Substances 0.000 claims description 5
- 229920001296 polysiloxane Polymers 0.000 claims description 5
- 229960004889 salicylic acid Drugs 0.000 claims description 5
- 229940057910 shea butter Drugs 0.000 claims description 5
- 229960003504 silicones Drugs 0.000 claims description 5
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 claims description 5
- 229940031439 squalene Drugs 0.000 claims description 5
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 5
- 239000010677 tea tree oil Substances 0.000 claims description 5
- 229940111630 tea tree oil Drugs 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 4
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003537 Vitamin B3 Natural products 0.000 claims description 4
- 229930003571 Vitamin B5 Natural products 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- 229930003448 Vitamin K Natural products 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 4
- 229960002079 calcium pantothenate Drugs 0.000 claims description 4
- 229940110456 cocoa butter Drugs 0.000 claims description 4
- 235000019868 cocoa butter Nutrition 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 4
- 235000019160 vitamin B3 Nutrition 0.000 claims description 4
- 239000011708 vitamin B3 Substances 0.000 claims description 4
- 235000009492 vitamin B5 Nutrition 0.000 claims description 4
- 239000011675 vitamin B5 Substances 0.000 claims description 4
- 235000019166 vitamin D Nutrition 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 4
- 235000019168 vitamin K Nutrition 0.000 claims description 4
- 239000011712 vitamin K Substances 0.000 claims description 4
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 229940046008 vitamin d Drugs 0.000 claims description 4
- 229940046010 vitamin k Drugs 0.000 claims description 4
- 241000271309 Aquilaria crassna Species 0.000 claims description 3
- 244000080208 Canella winterana Species 0.000 claims description 3
- 235000008499 Canella winterana Nutrition 0.000 claims description 3
- 240000000981 Citrus hystrix Species 0.000 claims description 3
- 235000002320 Citrus hystrix Nutrition 0.000 claims description 3
- 235000011203 Origanum Nutrition 0.000 claims description 3
- 241001529744 Origanum Species 0.000 claims description 3
- NJSSICCENMLTKO-HRCBOCMUSA-N [(1r,2s,4r,5r)-3-hydroxy-4-(4-methylphenyl)sulfonyloxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)O[C@H]1C(O)[C@@H](OS(=O)(=O)C=2C=CC(C)=CC=2)[C@@H]2OC[C@H]1O2 NJSSICCENMLTKO-HRCBOCMUSA-N 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 239000001877 cajuput oil Substances 0.000 claims description 3
- 239000001772 cananga odorata hook. f. and thomas. oil Substances 0.000 claims description 3
- 150000001765 catechin Chemical class 0.000 claims description 3
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 3
- 235000005487 catechin Nutrition 0.000 claims description 3
- 229940017545 cinnamon bark Drugs 0.000 claims description 3
- 239000010632 citronella oil Substances 0.000 claims description 3
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 claims description 3
- 239000010634 clove oil Substances 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 239000010643 fennel seed oil Substances 0.000 claims description 3
- 239000010649 ginger oil Substances 0.000 claims description 3
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 claims description 3
- 235000017807 phytochemicals Nutrition 0.000 claims description 3
- 229930000223 plant secondary metabolite Natural products 0.000 claims description 3
- 239000001738 pogostemon cablin oil Substances 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 150000003141 primary amines Chemical class 0.000 claims description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 3
- 239000010668 rosemary oil Substances 0.000 claims description 3
- 229940058206 rosemary oil Drugs 0.000 claims description 3
- 239000010671 sandalwood oil Substances 0.000 claims description 3
- 239000010679 vetiver oil Substances 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 229920001219 Polysorbate 40 Polymers 0.000 claims description 2
- 229920006318 anionic polymer Polymers 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 229920006317 cationic polymer Polymers 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 2
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 claims description 2
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 claims description 2
- 229940068977 polysorbate 20 Drugs 0.000 claims description 2
- 229940101027 polysorbate 40 Drugs 0.000 claims description 2
- 229940068968 polysorbate 80 Drugs 0.000 claims description 2
- 150000003335 secondary amines Chemical class 0.000 claims description 2
- 150000003512 tertiary amines Chemical class 0.000 claims description 2
- 239000000693 micelle Substances 0.000 abstract description 27
- 238000005187 foaming Methods 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 80
- 238000009472 formulation Methods 0.000 description 57
- 239000004372 Polyvinyl alcohol Substances 0.000 description 41
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 41
- 229920002451 polyvinyl alcohol Polymers 0.000 description 41
- 239000012153 distilled water Substances 0.000 description 37
- 238000002360 preparation method Methods 0.000 description 37
- 239000000499 gel Substances 0.000 description 34
- 239000004094 surface-active agent Substances 0.000 description 28
- 229920000136 polysorbate Polymers 0.000 description 26
- 238000013019 agitation Methods 0.000 description 24
- 229920002118 antimicrobial polymer Polymers 0.000 description 22
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 22
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 21
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 21
- ZBJCYZPANVLBRK-UHFFFAOYSA-N Menthone 1,2-glyceryl ketal Chemical compound CC(C)C1CCC(C)CC11OC(CO)CO1 ZBJCYZPANVLBRK-UHFFFAOYSA-N 0.000 description 19
- 239000002253 acid Substances 0.000 description 19
- 230000000844 anti-bacterial effect Effects 0.000 description 19
- 230000035876 healing Effects 0.000 description 19
- 238000010979 pH adjustment Methods 0.000 description 19
- 229920001223 polyethylene glycol Polymers 0.000 description 18
- 241000588724 Escherichia coli Species 0.000 description 15
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 14
- 239000000084 colloidal system Substances 0.000 description 14
- 229940043259 farnesol Drugs 0.000 description 14
- 239000000839 emulsion Substances 0.000 description 13
- 238000002525 ultrasonication Methods 0.000 description 13
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 12
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 12
- DUDCYUDPBRJVLG-UHFFFAOYSA-N ethoxyethane methyl 2-methylprop-2-enoate Chemical compound CCOCC.COC(=O)C(C)=C DUDCYUDPBRJVLG-UHFFFAOYSA-N 0.000 description 12
- 229930002886 farnesol Natural products 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 229920001427 mPEG Polymers 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 12
- 210000003013 erythroid precursor cell Anatomy 0.000 description 11
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 description 11
- 239000011257 shell material Substances 0.000 description 10
- 239000003623 enhancer Substances 0.000 description 9
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 9
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 9
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 239000002562 thickening agent Substances 0.000 description 9
- 229920002415 Pluronic P-123 Polymers 0.000 description 8
- 229920001992 poloxamer 407 Polymers 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 229920002907 Guar gum Polymers 0.000 description 7
- 239000000665 guar gum Substances 0.000 description 7
- 235000010417 guar gum Nutrition 0.000 description 7
- 229960002154 guar gum Drugs 0.000 description 7
- 238000001000 micrograph Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 235000019499 Citrus oil Nutrition 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 239000010500 citrus oil Substances 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- AIYMBFSABZEWQF-UHFFFAOYSA-N 2-chloro-2-methylpentan-3-amine Chemical compound NC(C(C)(C)Cl)CC AIYMBFSABZEWQF-UHFFFAOYSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 230000003330 sporicidal effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- 230000003253 viricidal effect Effects 0.000 description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003214 anti-biofilm Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000005541 medical transmission Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Definitions
- the disclosure of the present patent application relates to disinfectants, and particularly to hand foam sanitizers and hand gel sanitizers containing disinfecting capsules.
- the hand sanitizer may be a hand foam sanitizer or a hand gel sanitizer.
- Each of the hand sanitizers includes at least one stabilizing agent, at least one skin care agent, and a volume of disinfecting micelle capsules suspended therein.
- Each disinfecting capsule has a polymer shell which defines a hollow core.
- the polymer shell includes an antimicrobial material.
- the antimicrobial material may have a concentration of between 0.5 wt % and 95 wt % of the polymer shell.
- at least one foaming agent is added to produce a foam by air foaming.
- the at least one foaming agent and the at least one stabilizing agent are selected to maintain a size and shape of the foam for at least 60 seconds at room temperature (25° C.).
- Non-limiting examples of the at least one foaming agent include soap, liquid soap, powdered detergent, liquid detergent, sodium dodecyl sulfate, surfactants, and combinations thereof.
- Non-limiting examples of the at least one stabilizing agent include nonionic surfactants, emulsifying agents, polysorbate 20, polysorbate 40, polysorbate 80, and combinations thereof.
- Non-limiting examples of the at least one skin care include at least one moisturizer, at least one skin repair agent, at least one emollient, at least one vitamin, and combinations thereof.
- the at least one skin care agent may include hyaluronic acid, sodium hyaluronic, vitamin E, ceramides, sodium PCA, glycerin, glycerol, silicones, petrolatum, salicylic acid, alpha hydroxy acids, vitamin C, hyaluronic acid, beta-glucan, shea butter, mineral oil, plant butter, cocoa butter, lanolin, petrolatum, paraffin, beeswax, squalene, cetyl alcohol, triethyhexanoin, vitamin A, vitamin D, vitamin K, vitamin B3, vitamin B5, choline, and combinations thereof.
- the polymer shell includes at least one polymer, including, but not limited to, anionic polymers, cationic polymers, nonionic polymers and combinations thereof.
- the at least one polymer include primary amines, secondary amines, tertiary amines, zwitterionics, quaternary ammoniums, polyethylenimine, polyquaternium, polyhexamethylene biguanide, poly(diallyldimethylammonium chloride, functionalized chitosan, as well as any other suitable polymers with bactericidal, virucidal and sporicidal activities, and combinations thereof.
- each disinfecting capsule may be filled with a material, such as at least one disinfectant, at least one fragrance, at least one supplemental skin care agent, or combinations thereof.
- a material such as at least one disinfectant, at least one fragrance, at least one supplemental skin care agent, or combinations thereof.
- the at least one disinfectant include alcohol, chlorhexidine, antimicrobial phytochemicals, antimicrobial essential oils, agarwood oil, cajuput oil, cananga oil, cinnamon bark oil, citronella oil, clove oil, eucalyptus oil, fennel oil, ginger oil, kaffir lime oil, nutmeg oil, ollium xanthorrhiza oil, origanum oil, patchouli oil, rosemary oil, sandalwood oil, tea tree oil, thyme oil, vetiver oil and combinations thereof.
- Non-limiting examples of the at least one fragrance include essential oils of flowers, essential oils of fruits, essential oils of aromatic woods and combinations thereof.
- Non-limiting examples of the at least one supplemental skin care agent include hyaluronic acid, sodium hyaluronic, vitamin E, ceramides, sodium PCA, glycerin, glycerol, silicones, petrolatum, salicylic acid, alpha hydroxy acids, beta-glucan, mineral oil, plant butters, shea butter, cocoa butter, lanolin, petrolatum, paraffin, beeswax, squalene, cetyl alcohol, triethyhexanoin, vitamin A, vitamin C, vitamin E, vitamin D, vitamin K, vitamin B3, vitamin B5, choline, catechins and combinations thereof.
- an aqueous polymer solution of at least one polymer is mixed with a material to form a mixture.
- the material may include at least one disinfectant, at least one fragrance, at least one skin care agent, or combinations thereof.
- the at least one polymer includes an antimicrobial material, and the resultant mixture forms an aqueous solution of the disinfecting capsules.
- At least one stabilizing agent and at least one skin care agent are mixed with the mixture to form a suspension of the disinfecting capsules in the at least one stabilizing agent and the at least one skin care agent.
- the mixture is further mixed with at least one foaming agent.
- the hand foam sanitizer may be prepared by providing a skin care ingredient-containing solution separately from a suspension containing the at least one foaming agent and the volume of disinfecting capsules suspended therein.
- the skin care ingredient-containing solution can then be selectively mixed with the suspension at a desired ratio.
- the skin care ingredient(s) and foaming agent(s) may be any desired skin care ingredient(s) and foaming agent(s), such as those described with regard to the previous embodiments.
- FIG. 1 A is a 500 ⁇ microscope image of disinfecting capsules made from antimicrobial polymer polyethylenimine (PEI) (type A1).
- PEI antimicrobial polymer polyethylenimine
- FIG. 1 B is a 500 ⁇ microscope image of disinfecting capsules made from a combination of PEI and polyhexamethylene biguanide (PHMB) (type D1).
- PHMB polyhexamethylene biguanide
- FIG. 2 A is a 200 ⁇ microscope image of type D3 disinfecting capsules with no additional surfactant.
- FIG. 2 B is a 200 ⁇ microscope image of type D3 disinfecting capsules with 0.1 wt % sodium dodecyl sulfate (SDS) as a surfactant.
- SDS sodium dodecyl sulfate
- FIG. 2 C is a 200 ⁇ microscope image of type D3 disinfecting capsules with 0.2 wt % sodium dodecyl sulfate (SDS) as a surfactant.
- SDS sodium dodecyl sulfate
- FIG. 3 is a graph comparing the bactericidal properties of disinfecting capsules of types A1, B1, C1, D1, E1 and F1 against 10 5 CFU S. aureus for a contact time of 60 seconds.
- FIG. 4 is a 200 ⁇ microscope image of a suspension of type A1 disinfecting capsules with thyme oil.
- FIG. 5 is a 200 ⁇ microscope image of a suspension of type A1 disinfecting capsules with farnesol.
- FIG. 6 is an image showing a comparison between a control sample and (S0) type A1 disinfecting capsules, (S1) type A1 disinfecting capsules with 35 ppm farnesol, (S2) type A1 disinfecting capsules with 70 ppm farnesol, (S3) type A1 disinfecting capsules with 350 ppm farnesol, and (S4) type A1 disinfecting capsules with 700 ppm farnesol, each for a contact time of 60 seconds with 10 5 S. aureus.
- FIG. 7 A is a graph showing the bactericidal activity of a hand foam sanitizer (formulation 2) as a function of contact time for samples applied for 5, 60, 120, 180 and 240 minutes before testing against 10 5 CFU E. coli.
- FIG. 7 B is a graph showing the bactericidal activity of a conventional alcohol-based hand sanitizer as a function of contact time for samples applied for 5, 60, 120, 180 and 240 minutes before testing against 10 5 CFU E. coli.
- FIG. 8 is a graph showing the bactericidal activity of a hand foam sanitizer (formulation 10) as a function of contact time for samples applied for 5, 60, 120, 180 and 240 minutes before testing against 10 5 CFU E. coli.
- FIG. 9 is a graph showing the bactericidal activity of a hand foam sanitizer (formulation 11) as a function of contact time for samples applied for 5, 60, 120, 180 and 240 minutes before testing against 10 5 CFU E. coli.
- FIG. 10 shows a comparison of bactericidal activity between (a) a control sample, (b) a hand gel sanitizer (formulation 8) with a contact time of 30 seconds against 10 5 CFU E. coli ., and (c) the hand gel sanitizer (formulation 8) with a contact time of 60 seconds against 10 5 CFU E. coli.
- the hand sanitizers include formulations for water-based hand sanitizers, such as hand foams and hand gels, which are effective for killing germs and microbes.
- the hand sanitizers disinfect by contact-killing, anti-adhesion and/or release-killing, and can further store and release fragrance and skin-care ingredients over time.
- the hand sanitizers contain disinfecting capsules of micelles structures, which store active disinfectants, fragrances, and/or skin-care ingredients within an encapsulating shell.
- the shell possesses one or more antimicrobial properties, such as contact-killing, anti-adhesion and/or anti-biofilm.
- the encapsulating shell also controls the dosing of the stored disinfectants, fragrances and/or skin-care ingredients, thus prolonging their effectiveness.
- the hand sanitizers provide long-term protection against germs and microorganisms.
- the disinfecting micelle capsules include an antimicrobial polymeric shell and a core-space for storing active disinfectants, fragrance and skin-care ingredients that are slow-released to provide long-term performance.
- the formulations of the hand sanitizers include ingredients such as disinfectants, fragrances, polymers, foaming agents and stabilizers, thickener and viscosity enhancers, and skin-care ingredients that provide moisturizing and/or skin repair and/or emollient and/or vitamin for care of the skin.
- the stored disinfectants include, but are not limited to, common disinfectant solutions, such as alcohol, chlorhexidine and other chemical or mineral disinfectants, as well as phytochemicals that exhibit antimicrobial properties, including essential oils and their active antimicrobial components.
- the essential oils include, but are not limited to, agarwood oil, cajuput oil, cananga oil, cinnamon bark oil, citronella oil, clove oil, eucalyptus oil, fennel oil, ginger oil, kaffir lime oil, nutmeg oil, ollium xanthorrhiza oil, origanum oil, patchouli oil, rosemary oil, sandalwood oil, tea tree oil, thyme oil, vetiver oil or other plant-derived extracts that exhibit antimicrobial properties.
- the stored fragrances include, but are not limited to, natural and synthetic essence of flowers, fruits and aromatic woods that are pleasant to smell and provide olfactory pleasure. Fragrance may also be added to provide an olfactory cue for the presence of the disinfection function.
- the stored skin-care ingredients include, but are not limited to, moisturizers, such as hyaluronic acid, sodium hyaluronic, vitamin E, ceramides, sodium PCA, glycerin, glycerol, silicones, petrolatum, salicylic acid, alpha hydroxy acids and others with similar functions or properties; active ingredients that promote skin repair, such as vitamin C, hyaluronic acid, beta-glucan, ceramides, shea butter and others with similar functions or properties; emollients, such as mineral oil, plant butters (e.g., shea and cocoa), lanolin, petrolatum, paraffin, beeswax, squalene, cetyl alcohol, triethyhexanoin and others with similar functions or properties; vitamins, such as vitamins A, C, E, D, K, B3, B5; and anti-oxidants, such as vitamin C, choline, catechins and others with similar functions or properties.
- the stored materials may be a
- the shell of the micelles structure is formed of polymers with antimicrobial properties and the ability to release the stored materials over time.
- Polymers with one or more antimicrobial properties form 0.5 to 95 wt % of the shell material and include, but are not limited to, anionic, cationic and nonionic polymers, where the polymers may contain primary, secondary and tertiary amines, zwitterionics, or quaternary ammoniums.
- PEI polyethylenimine
- PHMB polyhexamethylene biguanide
- PDDA poly(diallyldimethylammonium chloride
- CHI functionalized chitosan
- the chemical structure for the exemplary polyethylenimine (PEI) is shown below:
- the disinfecting capsules form a micelles structure and a stable colloid that is incorporated in the formulation of water-based hand sanitizers as an antimicrobial ingredient, providing prolonged disinfection and also releasing fragrances and/or skin-care ingredient over time.
- the formulations for the water-based hand foam sanitizers include the disinfecting capsules, foaming and stabilizing agents and skin-care ingredients, which are suitable for air-foaming.
- the hand sanitizers may also include the disinfecting capsules, thickeners and viscosity enhancers, and skin-care ingredients, for producing a liquid gel for hand disinfection.
- FIG. 1 A shows disinfecting capsules made from the exemplary antimicrobial polymer polyethylenimine (PEI), and FIG. 1 B shows disinfecting capsules made from the exemplary combination of PEI and polyhexamethylene biguanide (PHMB).
- FIGS. 1 A and 1 B are each 500 ⁇ magnifications. The sizes of the capsules are tunable using surfactants and co-solvents, such as, for example, alcohols. This can be seen in FIGS. 2 A, 2 B and 2 C , with 0 wt %, 0.1 wt % and 0.2 wt % sodium dodecyl sulfate (SDS) as a surfactant, respectively.
- SDS sodium dodecyl sulfate
- FIG. 1 A the PEI disinfecting capsules are referred to herein as capsules A1, as will be described in detail with reference to Example 1 below.
- the combination PEI and PHMB capsules of FIG. 1 B are referred to herein as capsules D1, as will be described in greater detail with reference to Example 10 below.
- capsules D3 Each of the capsules shown in FIGS. 2 A, 2 B and 2 C are referred to herein as capsules D3, as will be described in greater detail in Example 12 below.
- FIG. 3 compares the bactericidal properties of capsules A1 (Example 1), B1 (Example 4), C1 (Example 7), D1 (Example 10), E1 (Example 13), and F1 (Example 16).
- FIG. 4 is a 200 ⁇ magnification showing a suspension of capsules A1 in thyme oil
- FIG. 5 is a 200 ⁇ magnification showing a suspension of capsules A1 in farnesol. It can be clearly seen that the capsules are larger with the stored disinfectants.
- FIG. 6 shows the bactericidal properties of the A1-farnesol suspension for contact of 60 seconds with 10 5 S.
- FIG. 6 further illustrates the storage capability of the disinfecting capsules and the release of the active content.
- the S0 sample shows a 90% reduction in viable bacteria
- the S1 sample shows a 97% reduction in viable bacteria
- the S2 sample shows a 97.5% reduction in viable bacteria
- the S3 sample shows a 98.8% reduction in viable bacteria
- the S4 sample shows a 99.25% reduction in viable bacteria.
- Example 38 (formulation 1) below is an active sanitizer and, when applied, achieved better than 99% decrease in viable E. coli (10 5 CFU) within 60 seconds of contact.
- the formulation contained disinfecting capsules A1.
- a colorant can be added to the hand sanitizer to produce foams of different colors.
- Disinfecting capsules containing thyme oil are also stable and can produce stable foam.
- Hand disinfection was performed according to the following procedure: The hands were sanitized with 75% vol. of ethanol for 15 seconds, rinsed with tap water for 20 seconds, and dried with two pieces of clean paper towel, followed by 1 minute of air drying. The fingertips on the left hand were sampled. Afterward, 1 milliliter of foam was applied and spread evenly over the hand and dried by rubbing the hands together. A suspension containing ten microliters of E. coli (10 6 CFU) was evenly spread over a 1 cm 2 area of each fingertip. The fingertips were then sampled, one after the other, following 3, 5, 10, 15 and 30 minutes of bacterial challenge. The sampling was done by gently pressing the fingers onto agar and rolling it for 5 seconds. The recovered viable E. coli was then counted.
- FIGS. 7 A, 7 B, 8 and 9 show that the hand foam sanitizers have persistent disinfection properties and can keep the hands clean from microbial contamination up to 4 hours after usage. It can be seen that the recoverable E. coli was less than 1.2% on hands disinfected with the hand foam sanitizers.
- FIG. 7 A shows the bactericidal activity of a hand foam sanitizer made from formulation 2 of Example 39 below as a function of contact time for samples applied over 5, 60, 120, 180 and 240 minutes before the test.
- FIG. 7 A shows the bactericidal activity of a hand foam sanitizer made from formulation 2 of Example 39 below as a function of contact time for samples applied over 5, 60, 120, 180 and 240 minutes before the test.
- FIG. 7 B is a comparison using the same parameters for a conventional alcohol-based hand sanitizer.
- the measured bactericidal activity was against 10 5 CFU E. coli .
- FIG. 8 shows the bactericidal activity of a hand foam sanitizer made from formulation 10 of Example 47 below as a function of contact time for samples applied over 5, 60, 120, 180 and 240 minutes before the test. The measured bactericidal activity was against 10 5 CFU E. coli .
- FIG. 9 shows the bactericidal activity of a hand foam sanitizer made from formulation 11 of Example 48 below as a function of contact time for samples applied over 5, 60, 120, 180 and 240 minutes before the test. The measured bactericidal activity was against 10 5 CFU E. coli.
- FIG. 10 shows that a hand gel sanitizer using the disinfecting capsules also possessed similarly high bactericidal activities, even at a very short contact time of 30 seconds.
- the “a” sample represents a control
- the “b” sample shows contact of 30 seconds using a hand gel sanitizer with formulation 8 of Example 45 below
- the “c” sample shows contact of 60 seconds using the hand gel sanitizer with formulation 8 of Example 45 below.
- the measured bactericidal activity is >99% against 10 5 CFU E. coli.
- a hand foam sanitizer may be prepared by providing a skin care ingredient-containing solution separately from a suspension containing the at least one foaming agent and the volume of disinfecting capsules suspended therein.
- the skin care ingredient-containing solution can then be selectively mixed with the suspension at a desired ratio.
- the skin care ingredient(s) and foaming agent(s) may be any desired skin care ingredient(s) and foaming agent(s), such as those described with regard to the previous embodiments.
- a solution of 0.1-40 wt % polyethylenimine and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension, which was generally transparent to translucent in appearance.
- the polymer can be cross-linked with a third polymer, such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- a solution of 0.1-40 wt % polyethylenimine and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance.
- the polymer can be cross-linked with a third polymer, such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- a solution of 0.1-40 wt % polyethylenimine and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance.
- the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- a solution of 0.1-30 wt % polyhexamethylene biguanide and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance.
- a solution of 0.1-30 wt % polyhexamethylene biguanide and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance.
- a solution of 0.1-30 wt % polyhexamethylene biguanide and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance.
- a solution of 0.1-40 wt % poly diallyldimethylammonium chloride and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance.
- a solution of 0.1-40 wt % poly diallyldimethylammonium chloride and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance.
- a solution of 0.1-40 wt % poly diallyldimethylammonium chloride and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance.
- a solution of 0.1-40 wt % polyethylenimine, 0.01 to 5 wt % polyhexamethylene biguanide, and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance.
- the polymer can be cross-linked with a third polymer, such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- a solution of 0.1-40 wt % polyethylenimine, 0.01 to 5 wt % polyhexamethylene biguanide, and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance.
- the polymer can be cross-linked with a third polymer, such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- a solution of 0.1-40 wt % polyethylenimine, 0.01 to 5 wt % polyhexamethylene biguanide, and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance.
- the polymer can be cross-linked with a third polymer, such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- a solution of 0.1-40 wt % polyethylenimine, 0.01 to 20 wt % poly diallyldimethylammonium chloride, and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance.
- the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- a solution of 0.1-40 wt % polyethylenimine, 0.01 to 20 wt % poly diallyldimethylammonium chloride, and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance.
- the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- a solution of 0.1-40 wt % polyethylenimine, 0.01 to 20 wt % poly diallyldimethylammonium chloride, and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance.
- the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- a solution of 0.1-40 wt % polyethylenimine, 0.01 to 20 wt % poly diallyldimethylammonium chloride, 0.01 to 5 wt % polyhexamethylene biguanide, and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance.
- the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- a solution of 0.1-40 wt % polyethylenimine, 0.01 to 20 wt % poly diallyldimethylammonium chloride, 0.01 to 5 wt % polyhexamethylene biguanide, and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance.
- the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- a solution of 0.1-40 wt % polyethylenimine, 0.01 to 20 wt % poly diallyldimethylammonium chloride, 0.01 to 5 wt % polyhexamethylene biguanide, and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance.
- the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- a solution of 0.1-40 wt % chitosan or functionalized chitosan of molecular weight of 5000 to 120000 g/mole and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance.
- a solution of 0.1-40 wt % chitosan or functionalized chitosan of molecular weight of 5000 to 120000 g/mole and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance.
- a solution of 0.1-40 wt % chitosan or functionalized chitosan of molecular weight of 5000 to 120000 g/mole and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance.
- a solution of 0.1 to 40 wt % polyquaterniums including, but not limited to, hydroxyethylcellulose ethoxylate quaternized, and poly[(2-ethyldimethyl-ammonioethyl chloride)-co-(1-vinylpyrrolidone] of molecular weights ranging from 5000 to 1000000 g/mol was dissolved in sterile distilled water, and then added to a 0.1 to 10 wt % polyvinyl alcohol solution in volume ratios from 5:1 to 1:5.
- a colloidal suspension that was generally transparent to translucent in appearance was produced, following mixing under strong agitation.
- a solution of 0.1 to 40 wt % polyquaterniums including, but not limited to hydroxyethylcellulose ethoxylate quaternized, and poly[(2-ethyldimethyl-ammonioethyl chloride)-co-(1-vinylpyrrolidone] of molecular weights ranging from 5000 to 1000000 g/mol was dissolved in sterile distilled water, and then added to a 0.1 to 10 wt % Pluronic P123 or Pluronic F127 solution in volume ratios from 5:1 to 1:5.
- a colloidal suspension that was generally transparent to translucent in appearance was produced, following mixing under strong agitation.
- a solution of 0.1 to 40 wt % polyquaterniums including, but not limited to, hydroxyethylcellulose ethoxylate quaternized, and poly[(2-ethyldimethyl-ammonioethyl chloride)-co-(1-vinylpyrrolidone] of molecular weights ranging from 5000 to 1000000 g/mol was dissolved in sterile distilled water, and then added to a 0.1 to 10 wt % polyvinylpyrrolidone in volume ratios from 5:1 to 1:5.
- a colloidal suspension that was generally transparent to translucent in appearance was produced, following mixing under strong agitation.
- Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %.
- a measured amount of thyme oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified.
- the polymer solution and the emulsion containing thyme oil were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules.
- Tween® 80 a polysorbate surfactant, was added to stabilize the colloid.
- Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %.
- a measured amount of farnesol dissolved in dimethyl sulfoxide (DMSO)/water solution to give a final concentration in the range of 10 wt % to 50 wt % was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified.
- the polymer solution and the emulsion containing farnesol were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid.
- Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %.
- a measured amount of thyme oil mixed with citrus oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified.
- the polymer solution and the emulsion containing essential oils were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules.
- Tween® 80 was added to stabilize the colloid.
- Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %.
- a measured amount of thyme oil mixed with lavender oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified.
- the polymer solution and the emulsion containing essential oils were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules.
- Tween® 80 was added to stabilize the colloid.
- Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %.
- a measured amount of a mixture of thyme oil, citrus oil and vitamin E was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified.
- the polymer solution and the emulsion containing the disinfectant, fragrance and skin-care ingredients were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules.
- Tween® 80 was added to stabilize the colloid.
- Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %.
- a measured amount of 80 wt % thymol dissolved in dipropylene glycol (DPG) was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified.
- the polymer solution and the emulsion containing the disinfectant, fragrance and skin-care ingredients were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules.
- Tween® 80 was added to stabilize the colloid.
- Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %.
- a measured amount of isopropanol was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified.
- the polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules.
- Tween® 80 was added to stabilize the colloid.
- Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %.
- a measured amount of chlorhexidine was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified.
- the polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules.
- Tween® 80 was added to stabilize the colloid.
- Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %.
- a measured amount of thyme oil was added to 0.1 to 10 wt % polyvinyl pyrrolidone solution and emulsified.
- the polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules.
- Tween® 80 was added to stabilize the colloid.
- a solution of 0.1-40 wt % polyethylenimine and 0.01 to 5 wt % polyhexamethylene biguanide was dissolved in sterile distilled water.
- a measured amount of thyme oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified.
- the polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules.
- Tween® 80 was added to stabilize the colloid.
- a solution of 0.1-40 wt % polyethylenimine and 0.01 to 20 wt % poly diallyldimethylammonium chloride was dissolved in sterile distilled water.
- a measured amount of thyme oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified.
- the polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules.
- Tween® 80 was added to stabilize the colloid.
- a solution of 0.1-40 wt % polyethylenimine, 0.01 to 5 wt % polyhexamethylene biguanide and 0.01 to 20 wt % poly diallyldimethylammonium chloride was dissolved in sterile distilled water.
- a measure amount of thyme oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified.
- the polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid.
- a solution of 0.1-40 wt % chitosan or functionalized chitosan of molecular weight of 5000 to 120000 g/mole and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water.
- a measured amount of thyme oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified.
- the polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (ca 1 min) to produce disinfecting capsules.
- Tween® 80 was added to stabilize the colloid.
- Table 1 below is a composition of a hand foam sanitizer formed from A1 disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 2 shows the composition of a hand foam sanitizer formed from A1 disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Colorant can be added in form of colored dye or pigment.
- Table 3 shows a composition of a hand foam sanitizer formed from A1-thyme oil disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension. Disinfection remains active after 4 hours from application when compared to alcohol.
- Table 4 shows a composition of a hand foam sanitizer formed from A1-thyme oil disinfecting capsules with citrus oil fragrance, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 5 below shows a composition of a hand foam sanitizer formed from A1-thyme oil disinfecting capsules with lavender fragrance, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 6 shows a composition of a hand foam sanitizer formed from A1-thyme oil disinfecting capsules with lavender fragrance and vitamin E moisturizer, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 7 shows a composition of a hand foam sanitizer formed from A1-thyme oil disinfecting capsules with lavender oil fragrance, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 8 shows a composition of a hand foam sanitizer formed from B1-thyme oil disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 9 shows a composition of a hand foam sanitizer formed from D1-thyme oil disinfecting capsules with lavender oil fragrance, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 10 shows a composition of a hand foam sanitizer formed from D1-thyme oil disinfecting capsules with lavender oil fragrance, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 11 shows a composition of a hand foam sanitizer formed from A1-geraniol oil disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 12 below shows a composition of a hand foam sanitizer formed from A1-origanum oil disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 13 below shows a composition of a hand gel sanitizer formed from A1 disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 14 below shows a composition of a hand gel sanitizer formed from A1 disinfecting capsules and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 15 shows a composition of a hand gel sanitizer formed from A1-thyme oil disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 16 shows a composition of a hand gel sanitizer formed from A1-thyme oil disinfecting capsules with lavender oil fragrance and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 17 below shows a composition of a hand gel sanitizer formed from A1-thyme oil disinfecting capsules with lavender oil fragrance and vitamin E, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 18 shows a composition of a hand gel sanitizer comprising of A1-tea tree oil disinfecting capsules with lavender oil fragrance and eucalyptus oil, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 19 below shows a composition of a hand gel sanitizer formed from D1-thyme oil disinfecting capsules with lavender oil fragrance and vitamin E, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
- Table 20 below shows a composition of a hand gel sanitizer formed from D1-thyme oil disinfecting capsules with lavender oil fragrance and vitamin E, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension. The bactericidal tests were carried out on 10 5 CFU E. coli at 60 seconds contact.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
- The disclosure of the present patent application relates to disinfectants, and particularly to hand foam sanitizers and hand gel sanitizers containing disinfecting capsules.
- Unclean hands play an important role in the transmission of pathogens. Infection may occur when hands contaminated with pathogens touch the eyes, nose or lips, allowing microorganisms to enter through the mucous membranes thereof. Numerous studies support hand hygiene as being an important factor in reducing the carrying and transmission of pathogens on hands to prevent disease transmission and infection. However, according to the Centers for Disease Control and Prevention (CDC), only about 5% of people wash their hands long enough to destroy infectious germs after using the bathroom.
- Although a wide variety of hand washing devices and accessories exist, such as devices to monitor hand washing process or assist in hand washing for periods of about 15 seconds to remove germs, such devices and accessories are not widely used, as they are typically costly and difficult to install. Further, as with conventional washing, there is no certainty that the devices will be used, despite their presence and obvious utility.
- The use of both alcohol-based and alcohol-free antimicrobial hand gel and hand foam is another commonly used method for hand disinfection, particularly due to their convenience, low costs, and ease of application. However, alcohol-based hand sanitizers often leave the skin dry, and with repeated use, cause skin irritation. On the other hand, many alcohol-free products leave sticky residue on the skin. Another, disadvantage is that the sanitizers do not last long and disinfection lasts for only a short time. Thus, a hand sanitizer and method of making the same solving the aforementioned problems is desired.
- The hand sanitizer may be a hand foam sanitizer or a hand gel sanitizer. Each of the hand sanitizers includes at least one stabilizing agent, at least one skin care agent, and a volume of disinfecting micelle capsules suspended therein. Each disinfecting capsule has a polymer shell which defines a hollow core. The polymer shell includes an antimicrobial material. The antimicrobial material may have a concentration of between 0.5 wt % and 95 wt % of the polymer shell. In order to make the hand foam sanitizer, at least one foaming agent is added to produce a foam by air foaming. Preferably, the at least one foaming agent and the at least one stabilizing agent are selected to maintain a size and shape of the foam for at least 60 seconds at room temperature (25° C.).
- Non-limiting examples of the at least one foaming agent include soap, liquid soap, powdered detergent, liquid detergent, sodium dodecyl sulfate, surfactants, and combinations thereof. Non-limiting examples of the at least one stabilizing agent include nonionic surfactants, emulsifying agents, polysorbate 20, polysorbate 40, polysorbate 80, and combinations thereof. Non-limiting examples of the at least one skin care include at least one moisturizer, at least one skin repair agent, at least one emollient, at least one vitamin, and combinations thereof. As non-limiting examples, the at least one skin care agent may include hyaluronic acid, sodium hyaluronic, vitamin E, ceramides, sodium PCA, glycerin, glycerol, silicones, petrolatum, salicylic acid, alpha hydroxy acids, vitamin C, hyaluronic acid, beta-glucan, shea butter, mineral oil, plant butter, cocoa butter, lanolin, petrolatum, paraffin, beeswax, squalene, cetyl alcohol, triethyhexanoin, vitamin A, vitamin D, vitamin K, vitamin B3, vitamin B5, choline, and combinations thereof.
- The polymer shell includes at least one polymer, including, but not limited to, anionic polymers, cationic polymers, nonionic polymers and combinations thereof. Non-limiting examples of the at least one polymer include primary amines, secondary amines, tertiary amines, zwitterionics, quaternary ammoniums, polyethylenimine, polyquaternium, polyhexamethylene biguanide, poly(diallyldimethylammonium chloride, functionalized chitosan, as well as any other suitable polymers with bactericidal, virucidal and sporicidal activities, and combinations thereof.
- The hollow core of each disinfecting capsule may be filled with a material, such as at least one disinfectant, at least one fragrance, at least one supplemental skin care agent, or combinations thereof. Non-limiting examples of the at least one disinfectant include alcohol, chlorhexidine, antimicrobial phytochemicals, antimicrobial essential oils, agarwood oil, cajuput oil, cananga oil, cinnamon bark oil, citronella oil, clove oil, eucalyptus oil, fennel oil, ginger oil, kaffir lime oil, nutmeg oil, ollium xanthorrhiza oil, origanum oil, patchouli oil, rosemary oil, sandalwood oil, tea tree oil, thyme oil, vetiver oil and combinations thereof. Non-limiting examples of the at least one fragrance include essential oils of flowers, essential oils of fruits, essential oils of aromatic woods and combinations thereof. Non-limiting examples of the at least one supplemental skin care agent include hyaluronic acid, sodium hyaluronic, vitamin E, ceramides, sodium PCA, glycerin, glycerol, silicones, petrolatum, salicylic acid, alpha hydroxy acids, beta-glucan, mineral oil, plant butters, shea butter, cocoa butter, lanolin, petrolatum, paraffin, beeswax, squalene, cetyl alcohol, triethyhexanoin, vitamin A, vitamin C, vitamin E, vitamin D, vitamin K, vitamin B3, vitamin B5, choline, catechins and combinations thereof.
- In order to make the hand sanitizer, an aqueous polymer solution of at least one polymer is mixed with a material to form a mixture. The material may include at least one disinfectant, at least one fragrance, at least one skin care agent, or combinations thereof. The at least one polymer includes an antimicrobial material, and the resultant mixture forms an aqueous solution of the disinfecting capsules. At least one stabilizing agent and at least one skin care agent are mixed with the mixture to form a suspension of the disinfecting capsules in the at least one stabilizing agent and the at least one skin care agent. In order to make the hand foam sanitizer, the mixture is further mixed with at least one foaming agent.
- As a further alternative, the hand foam sanitizer may be prepared by providing a skin care ingredient-containing solution separately from a suspension containing the at least one foaming agent and the volume of disinfecting capsules suspended therein. The skin care ingredient-containing solution can then be selectively mixed with the suspension at a desired ratio. It should be understood that the skin care ingredient(s) and foaming agent(s) may be any desired skin care ingredient(s) and foaming agent(s), such as those described with regard to the previous embodiments.
- These and other features of the present subject matter will become readily apparent upon further review of the following specification.
-
FIG. 1A is a 500× microscope image of disinfecting capsules made from antimicrobial polymer polyethylenimine (PEI) (type A1). -
FIG. 1B is a 500× microscope image of disinfecting capsules made from a combination of PEI and polyhexamethylene biguanide (PHMB) (type D1). -
FIG. 2A is a 200× microscope image of type D3 disinfecting capsules with no additional surfactant. -
FIG. 2B is a 200× microscope image of type D3 disinfecting capsules with 0.1 wt % sodium dodecyl sulfate (SDS) as a surfactant. -
FIG. 2C is a 200× microscope image of type D3 disinfecting capsules with 0.2 wt % sodium dodecyl sulfate (SDS) as a surfactant. -
FIG. 3 is a graph comparing the bactericidal properties of disinfecting capsules of types A1, B1, C1, D1, E1 and F1 against 105 CFU S. aureus for a contact time of 60 seconds. -
FIG. 4 is a 200× microscope image of a suspension of type A1 disinfecting capsules with thyme oil. -
FIG. 5 is a 200× microscope image of a suspension of type A1 disinfecting capsules with farnesol. -
FIG. 6 is an image showing a comparison between a control sample and (S0) type A1 disinfecting capsules, (S1) type A1 disinfecting capsules with 35 ppm farnesol, (S2) type A1 disinfecting capsules with 70 ppm farnesol, (S3) type A1 disinfecting capsules with 350 ppm farnesol, and (S4) type A1 disinfecting capsules with 700 ppm farnesol, each for a contact time of 60 seconds with 105 S. aureus. -
FIG. 7A is a graph showing the bactericidal activity of a hand foam sanitizer (formulation 2) as a function of contact time for samples applied for 5, 60, 120, 180 and 240 minutes before testing against 105 CFU E. coli. -
FIG. 7B is a graph showing the bactericidal activity of a conventional alcohol-based hand sanitizer as a function of contact time for samples applied for 5, 60, 120, 180 and 240 minutes before testing against 105 CFU E. coli. -
FIG. 8 is a graph showing the bactericidal activity of a hand foam sanitizer (formulation 10) as a function of contact time for samples applied for 5, 60, 120, 180 and 240 minutes before testing against 105 CFU E. coli. -
FIG. 9 is a graph showing the bactericidal activity of a hand foam sanitizer (formulation 11) as a function of contact time for samples applied for 5, 60, 120, 180 and 240 minutes before testing against 105 CFU E. coli. -
FIG. 10 shows a comparison of bactericidal activity between (a) a control sample, (b) a hand gel sanitizer (formulation 8) with a contact time of 30 seconds against 105 CFU E. coli., and (c) the hand gel sanitizer (formulation 8) with a contact time of 60 seconds against 105 CFU E. coli. - Similar reference characters denote corresponding features consistently throughout the attached drawings.
- The hand sanitizers include formulations for water-based hand sanitizers, such as hand foams and hand gels, which are effective for killing germs and microbes. The hand sanitizers disinfect by contact-killing, anti-adhesion and/or release-killing, and can further store and release fragrance and skin-care ingredients over time. The hand sanitizers contain disinfecting capsules of micelles structures, which store active disinfectants, fragrances, and/or skin-care ingredients within an encapsulating shell. The shell possesses one or more antimicrobial properties, such as contact-killing, anti-adhesion and/or anti-biofilm. The encapsulating shell also controls the dosing of the stored disinfectants, fragrances and/or skin-care ingredients, thus prolonging their effectiveness. The hand sanitizers provide long-term protection against germs and microorganisms.
- The disinfecting micelle capsules include an antimicrobial polymeric shell and a core-space for storing active disinfectants, fragrance and skin-care ingredients that are slow-released to provide long-term performance. The formulations of the hand sanitizers, as will be described in greater detail below, include ingredients such as disinfectants, fragrances, polymers, foaming agents and stabilizers, thickener and viscosity enhancers, and skin-care ingredients that provide moisturizing and/or skin repair and/or emollient and/or vitamin for care of the skin.
- The stored disinfectants include, but are not limited to, common disinfectant solutions, such as alcohol, chlorhexidine and other chemical or mineral disinfectants, as well as phytochemicals that exhibit antimicrobial properties, including essential oils and their active antimicrobial components. The essential oils include, but are not limited to, agarwood oil, cajuput oil, cananga oil, cinnamon bark oil, citronella oil, clove oil, eucalyptus oil, fennel oil, ginger oil, kaffir lime oil, nutmeg oil, ollium xanthorrhiza oil, origanum oil, patchouli oil, rosemary oil, sandalwood oil, tea tree oil, thyme oil, vetiver oil or other plant-derived extracts that exhibit antimicrobial properties.
- The stored fragrances include, but are not limited to, natural and synthetic essence of flowers, fruits and aromatic woods that are pleasant to smell and provide olfactory pleasure. Fragrance may also be added to provide an olfactory cue for the presence of the disinfection function. The stored skin-care ingredients include, but are not limited to, moisturizers, such as hyaluronic acid, sodium hyaluronic, vitamin E, ceramides, sodium PCA, glycerin, glycerol, silicones, petrolatum, salicylic acid, alpha hydroxy acids and others with similar functions or properties; active ingredients that promote skin repair, such as vitamin C, hyaluronic acid, beta-glucan, ceramides, shea butter and others with similar functions or properties; emollients, such as mineral oil, plant butters (e.g., shea and cocoa), lanolin, petrolatum, paraffin, beeswax, squalene, cetyl alcohol, triethyhexanoin and others with similar functions or properties; vitamins, such as vitamins A, C, E, D, K, B3, B5; and anti-oxidants, such as vitamin C, choline, catechins and others with similar functions or properties. The stored materials may be a combination of one or more disinfectants, fragrances, and/or skin-care ingredients that are slowly released over time.
- The shell of the micelles structure is formed of polymers with antimicrobial properties and the ability to release the stored materials over time. Polymers with one or more antimicrobial properties form 0.5 to 95 wt % of the shell material and include, but are not limited to, anionic, cationic and nonionic polymers, where the polymers may contain primary, secondary and tertiary amines, zwitterionics, or quaternary ammoniums. Some examples include, but are not limited to, polyethylenimine (PEI), polyquaternium, polyhexamethylene biguanide (PHMB), poly(diallyldimethylammonium chloride (PDDA), functionalized chitosan (CHI) or similar polymers with bactericidal, virucidal or sporicidal activities. The chemical structure for the exemplary polyethylenimine (PEI) is shown below:
- The disinfecting capsules form a micelles structure and a stable colloid that is incorporated in the formulation of water-based hand sanitizers as an antimicrobial ingredient, providing prolonged disinfection and also releasing fragrances and/or skin-care ingredient over time. The formulations for the water-based hand foam sanitizers, as will be described in greater detail below, include the disinfecting capsules, foaming and stabilizing agents and skin-care ingredients, which are suitable for air-foaming. The hand sanitizers may also include the disinfecting capsules, thickeners and viscosity enhancers, and skin-care ingredients, for producing a liquid gel for hand disinfection.
-
FIG. 1A shows disinfecting capsules made from the exemplary antimicrobial polymer polyethylenimine (PEI), andFIG. 1B shows disinfecting capsules made from the exemplary combination of PEI and polyhexamethylene biguanide (PHMB).FIGS. 1A and 1B are each 500× magnifications. The sizes of the capsules are tunable using surfactants and co-solvents, such as, for example, alcohols. This can be seen inFIGS. 2A, 2B and 2C , with 0 wt %, 0.1 wt % and 0.2 wt % sodium dodecyl sulfate (SDS) as a surfactant, respectively.FIGS. 2A, 2B and 2C are each 200× magnifications. The disinfecting capsules without stored disinfectants are active for disinfection of microorganisms, as shown inFIG. 3 . InFIG. 1A , the PEI disinfecting capsules are referred to herein as capsules A1, as will be described in detail with reference to Example 1 below. The combination PEI and PHMB capsules ofFIG. 1B are referred to herein as capsules D1, as will be described in greater detail with reference to Example 10 below. Each of the capsules shown inFIGS. 2A, 2B and 2C are referred to herein as capsules D3, as will be described in greater detail in Example 12 below.FIG. 3 compares the bactericidal properties of capsules A1 (Example 1), B1 (Example 4), C1 (Example 7), D1 (Example 10), E1 (Example 13), and F1 (Example 16). -
FIG. 4 is a 200× magnification showing a suspension of capsules A1 in thyme oil, andFIG. 5 is a 200× magnification showing a suspension of capsules A1 in farnesol. It can be clearly seen that the capsules are larger with the stored disinfectants.FIG. 6 shows the bactericidal properties of the A1-farnesol suspension for contact of 60 seconds with 105 S. aureus, comparing a control sample against empty A1 disinfecting capsules (S0), A1 capsules with 35 ppm farnesol (S1), A1 capsules with 70 ppm farnesol (S2), A1 capsules with 350 ppm farnesol (S3), and A1 capsules with 700 ppm farnesol (S4).FIG. 6 further illustrates the storage capability of the disinfecting capsules and the release of the active content. The S0 sample shows a 90% reduction in viable bacteria, the S1 sample shows a 97% reduction in viable bacteria, the S2 sample shows a 97.5% reduction in viable bacteria, the S3 sample shows a 98.8% reduction in viable bacteria, and the S4 sample shows a 99.25% reduction in viable bacteria. - The formulation of Example 38 (formulation 1) below is an active sanitizer and, when applied, achieved better than 99% decrease in viable E. coli (105 CFU) within 60 seconds of contact. The formulation contained disinfecting capsules A1. A colorant can be added to the hand sanitizer to produce foams of different colors. Disinfecting capsules containing thyme oil are also stable and can produce stable foam.
- Hand disinfection was performed according to the following procedure: The hands were sanitized with 75% vol. of ethanol for 15 seconds, rinsed with tap water for 20 seconds, and dried with two pieces of clean paper towel, followed by 1 minute of air drying. The fingertips on the left hand were sampled. Afterward, 1 milliliter of foam was applied and spread evenly over the hand and dried by rubbing the hands together. A suspension containing ten microliters of E. coli (106 CFU) was evenly spread over a 1 cm2 area of each fingertip. The fingertips were then sampled, one after the other, following 3, 5, 10, 15 and 30 minutes of bacterial challenge. The sampling was done by gently pressing the fingers onto agar and rolling it for 5 seconds. The recovered viable E. coli was then counted. The experiment was carried out in triplicate. This was followed by a series of experiment where the bacteria was challenged on the fingertips after 5, 60, 120, 180 and 240 minutes of using the sanitizers.
FIGS. 7A, 7B, 8 and 9 show that the hand foam sanitizers have persistent disinfection properties and can keep the hands clean from microbial contamination up to 4 hours after usage. It can be seen that the recoverable E. coli was less than 1.2% on hands disinfected with the hand foam sanitizers.FIG. 7A shows the bactericidal activity of a hand foam sanitizer made fromformulation 2 of Example 39 below as a function of contact time for samples applied over 5, 60, 120, 180 and 240 minutes before the test.FIG. 7B is a comparison using the same parameters for a conventional alcohol-based hand sanitizer. For each ofFIGS. 7A and 7B , the measured bactericidal activity was against 105 CFU E. coli.FIG. 8 shows the bactericidal activity of a hand foam sanitizer made fromformulation 10 of Example 47 below as a function of contact time for samples applied over 5, 60, 120, 180 and 240 minutes before the test. The measured bactericidal activity was against 105 CFU E. coli.FIG. 9 shows the bactericidal activity of a hand foam sanitizer made from formulation 11 of Example 48 below as a function of contact time for samples applied over 5, 60, 120, 180 and 240 minutes before the test. The measured bactericidal activity was against 105 CFU E. coli. -
FIG. 10 shows that a hand gel sanitizer using the disinfecting capsules also possessed similarly high bactericidal activities, even at a very short contact time of 30 seconds. InFIG. 10 , the “a” sample represents a control, the “b” sample shows contact of 30 seconds using a hand gel sanitizer with formulation 8 of Example 45 below, and the “c” sample shows contact of 60 seconds using the hand gel sanitizer with formulation 8 of Example 45 below. The measured bactericidal activity is >99% against 105 CFU E. coli. - As a further alternative, a hand foam sanitizer may be prepared by providing a skin care ingredient-containing solution separately from a suspension containing the at least one foaming agent and the volume of disinfecting capsules suspended therein. The skin care ingredient-containing solution can then be selectively mixed with the suspension at a desired ratio. It should be understood that the skin care ingredient(s) and foaming agent(s) may be any desired skin care ingredient(s) and foaming agent(s), such as those described with regard to the previous embodiments.
- A solution of 0.1-40 wt % polyethylenimine and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension, which was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures. Also, if needed, the polymer can be cross-linked with a third polymer, such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- A solution of 0.1-40 wt % polyethylenimine and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures. Also, if needed, the polymer can be cross-linked with a third polymer, such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- A solution of 0.1-40 wt % polyethylenimine and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures. Also, if needed, the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- A solution of 0.1-30 wt % polyhexamethylene biguanide and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures.
- A solution of 0.1-30 wt % polyhexamethylene biguanide and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures.
- A solution of 0.1-30 wt % polyhexamethylene biguanide and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures.
- A solution of 0.1-40 wt % poly diallyldimethylammonium chloride and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures.
- A solution of 0.1-40 wt % poly diallyldimethylammonium chloride and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures.
- A solution of 0.1-40 wt % poly diallyldimethylammonium chloride and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures.
- A solution of 0.1-40 wt % polyethylenimine, 0.01 to 5 wt % polyhexamethylene biguanide, and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures. Also, if needed, the polymer can be cross-linked with a third polymer, such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- A solution of 0.1-40 wt % polyethylenimine, 0.01 to 5 wt % polyhexamethylene biguanide, and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures. Also, if needed, the polymer can be cross-linked with a third polymer, such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- A solution of 0.1-40 wt % polyethylenimine, 0.01 to 5 wt % polyhexamethylene biguanide, and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures. Also, if needed, the polymer can be cross-linked with a third polymer, such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- A solution of 0.1-40 wt % polyethylenimine, 0.01 to 20 wt % poly diallyldimethylammonium chloride, and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures. Also, if needed, the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- A solution of 0.1-40 wt % polyethylenimine, 0.01 to 20 wt % poly diallyldimethylammonium chloride, and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures. Also, if needed, the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- A solution of 0.1-40 wt % polyethylenimine, 0.01 to 20 wt % poly diallyldimethylammonium chloride, and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures. Also, if needed, the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- A solution of 0.1-40 wt % polyethylenimine, 0.01 to 20 wt % poly diallyldimethylammonium chloride, 0.01 to 5 wt % polyhexamethylene biguanide, and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures. Also, if needed, the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- A solution of 0.1-40 wt % polyethylenimine, 0.01 to 20 wt % poly diallyldimethylammonium chloride, 0.01 to 5 wt % polyhexamethylene biguanide, and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures. Also, if needed, the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- A solution of 0.1-40 wt % polyethylenimine, 0.01 to 20 wt % poly diallyldimethylammonium chloride, 0.01 to 5 wt % polyhexamethylene biguanide, and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures. Also, if needed, the polymer can be cross-linked with a third polymer such as poly(ethylene glycol) methacrylate or poly(ethylene glycol) methyl ether methacrylate of molecular weight of 500-1000 g/mol.
- A solution of 0.1-40 wt % chitosan or functionalized chitosan of molecular weight of 5000 to 120000 g/mole and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally transparent to translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures.
- A solution of 0.1-40 wt % chitosan or functionalized chitosan of molecular weight of 5000 to 120000 g/mole and 0.1 to 10 wt % Pluronic P123 or Pluronic F127 was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures.
- A solution of 0.1-40 wt % chitosan or functionalized chitosan of molecular weight of 5000 to 120000 g/mole and 0.1 to 10 wt % polyvinylpyrrolidone was dissolved in sterile distilled water and mixed under strong agitation to produce a colloidal suspension that was generally translucent in appearance. A small amount of surfactants, such as sodium dodecyl sulfate and/or ammonium lauryl sulfate, were added to control the size and shape of the micelle structures.
- A solution of 0.1 to 40 wt % polyquaterniums including, but not limited to, hydroxyethylcellulose ethoxylate quaternized, and poly[(2-ethyldimethyl-ammonioethyl chloride)-co-(1-vinylpyrrolidone] of molecular weights ranging from 5000 to 1000000 g/mol was dissolved in sterile distilled water, and then added to a 0.1 to 10 wt % polyvinyl alcohol solution in volume ratios from 5:1 to 1:5. A colloidal suspension that was generally transparent to translucent in appearance was produced, following mixing under strong agitation.
- A solution of 0.1 to 40 wt % polyquaterniums including, but not limited to hydroxyethylcellulose ethoxylate quaternized, and poly[(2-ethyldimethyl-ammonioethyl chloride)-co-(1-vinylpyrrolidone] of molecular weights ranging from 5000 to 1000000 g/mol was dissolved in sterile distilled water, and then added to a 0.1 to 10 wt % Pluronic P123 or Pluronic F127 solution in volume ratios from 5:1 to 1:5. A colloidal suspension that was generally transparent to translucent in appearance was produced, following mixing under strong agitation.
- A solution of 0.1 to 40 wt % polyquaterniums including, but not limited to, hydroxyethylcellulose ethoxylate quaternized, and poly[(2-ethyldimethyl-ammonioethyl chloride)-co-(1-vinylpyrrolidone] of molecular weights ranging from 5000 to 1000000 g/mol was dissolved in sterile distilled water, and then added to a 0.1 to 10 wt % polyvinylpyrrolidone in volume ratios from 5:1 to 1:5. A colloidal suspension that was generally transparent to translucent in appearance was produced, following mixing under strong agitation.
- Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %. A measured amount of thyme oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified. The polymer solution and the emulsion containing thyme oil were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80, a polysorbate surfactant, was added to stabilize the colloid. - Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %. A measured amount of farnesol dissolved in dimethyl sulfoxide (DMSO)/water solution to give a final concentration in the range of 10 wt % to 50 wt % was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified. The polymer solution and the emulsion containing farnesol were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid. - Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %. A measured amount of thyme oil mixed with citrus oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified. The polymer solution and the emulsion containing essential oils were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid. - Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %. A measured amount of thyme oil mixed with lavender oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified. The polymer solution and the emulsion containing essential oils were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid. - Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %. A measured amount of a mixture of thyme oil, citrus oil and vitamin E was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified. The polymer solution and the emulsion containing the disinfectant, fragrance and skin-care ingredients were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid. - Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %. A measured amount of 80 wt % thymol dissolved in dipropylene glycol (DPG) was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified. The polymer solution and the emulsion containing the disinfectant, fragrance and skin-care ingredients were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid. - Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %. A measured amount of isopropanol was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified. The polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid. - Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %. A measured amount of chlorhexidine was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified. The polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid. - Polyethylenimine with a molecular weight of 1200 to 10000 g/mol was dissolved in sterile distilled water to prepare a polymer solution with concentrations of 1 to 20 wt %. A measured amount of thyme oil was added to 0.1 to 10 wt % polyvinyl pyrrolidone solution and emulsified. The polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid. - A solution of 0.1-40 wt % polyethylenimine and 0.01 to 5 wt % polyhexamethylene biguanide was dissolved in sterile distilled water. A measured amount of thyme oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified. The polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid. - A solution of 0.1-40 wt % polyethylenimine and 0.01 to 20 wt % poly diallyldimethylammonium chloride was dissolved in sterile distilled water. A measured amount of thyme oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified. The polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid. - A solution of 0.1-40 wt % polyethylenimine, 0.01 to 5 wt % polyhexamethylene biguanide and 0.01 to 20 wt % poly diallyldimethylammonium chloride was dissolved in sterile distilled water. A measure amount of thyme oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified. The polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid. - A solution of 0.1-40 wt % chitosan or functionalized chitosan of molecular weight of 5000 to 120000 g/mole and 0.1 to 10 wt % polyvinyl alcohol was dissolved in sterile distilled water. A measured amount of thyme oil was added to 0.1 to 10 wt % polyvinyl alcohol solution and emulsified. The polymer solution and the emulsion were mixed in volume ratios from 5:1 to 1:5, followed by rapid mixing and ultrasonication (
ca 1 min) to produce disinfecting capsules. Tween® 80 was added to stabilize the colloid. - Table 1 below is a composition of a hand foam sanitizer formed from A1 disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 1 Hand Foam Sanitizer Formulation 1Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Foam Stabilizer Tween ® 80 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 2 below shows the composition of a hand foam sanitizer formed from A1 disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension. Colorant can be added in form of colored dye or pigment.
-
TABLE 2 Hand Foam Sanitizer Formulation 1A Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Foam Stabilizer Tween 80 ® 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 3 below shows a composition of a hand foam sanitizer formed from A1-thyme oil disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension. Disinfection remains active after 4 hours from application when compared to alcohol.
-
TABLE 3 Hand Foam Sanitizer Formulation 2Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Thyme oil 0.03 Foam Stabilizer Tween ® 80 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 4 below shows a composition of a hand foam sanitizer formed from A1-thyme oil disinfecting capsules with citrus oil fragrance, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 4 Hand Foam Sanitizer Formulation 3Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Thyme oil 0.03 Fragrance Citrus oil 0.03 Foam Stabilizer Tween ® 80 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 5 below shows a composition of a hand foam sanitizer formed from A1-thyme oil disinfecting capsules with lavender fragrance, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 5 Hand Foam Sanitizer Formulation 4Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Thyme oil 0.03 Fragrance Lavender oil 0.03 Foam Stabilizer Tween ® 80 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 6 below shows a composition of a hand foam sanitizer formed from A1-thyme oil disinfecting capsules with lavender fragrance and vitamin E moisturizer, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 6 Hand Foam Sanitizer Formulation 5Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Thyme oil 0.03 Fragrance Lavender oil 0.03 Moisturizer Vitamin E 0.02 Foam Stabilizer Tween ® 80 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Sodium hyaluronic ≤0.02 Healing Freshness Frescolat ® MGA ≤0.02 Handfeel (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 7 below shows a composition of a hand foam sanitizer formed from A1-thyme oil disinfecting capsules with lavender oil fragrance, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 7 Hand Foam Sanitizer Formulation 6 Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Thyme oil 0.03 Fragrance Lavender oil 0.03 Foam Stabilizer Tween ® 80 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Sodium hyaluronic ≤0.02 Healing Vitamin E Emollient Cetyl alcohol ≤0.02 Vitamin and Antioxidant Vitamin C ≤0.02 Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid Optional (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 8 below shows a composition of a hand foam sanitizer formed from B1-thyme oil disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 8 Hand Foam Sanitizer Formulation 7 Component Ingredient Weight Percent Antimicrobial Polymer Polyhexamethylene biguanide 0.2 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Thyme oil 0.03 Foam Stabilizer Tween ® 80 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 9 below shows a composition of a hand foam sanitizer formed from D1-thyme oil disinfecting capsules with lavender oil fragrance, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 9 Hand Foam Sanitizer Formulation 8 Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Polyhexamethylene biguanide 0.1 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Thyme oil 0.03 Fragrance Lavender oil 0.03 Foam Stabilizer Tween ® 80 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Sodium hyaluronic ≤0.02 Healing Vitamin E Emollient Cetyl alcohol ≤0.02 Vitamin and Vitamin C ≤0.02 Antioxidant Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 10 below shows a composition of a hand foam sanitizer formed from D1-thyme oil disinfecting capsules with lavender oil fragrance, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 10 Hand Foam Sanitizer Formulation 9 Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Polyhexamethylene biguanide 0.1 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Thyme oil 0.03 Fragrance Lavender oil 0.03 Skin-care Vitamin E 0.02 Foam Stabilizer Tween ® 80 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Sodium hyaluronic ≤0.02 Healing Emollient Cetyl alcohol ≤0.02 Vitamin and Vitamin C ≤0.02 Antioxidant Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 11 below shows a composition of a hand foam sanitizer formed from A1-geraniol oil disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 11 Hand Foam Sanitizer Formulation 10Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Gerariol oil 0.03 Foam Stabilizer Tween ® 80 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 12 below shows a composition of a hand foam sanitizer formed from A1-origanum oil disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 12 Hand Foam Sanitizer Formulation 11 Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Origarum oil 0.03 Foam Stabilizer Tween ® 80 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 13 below shows a composition of a hand gel sanitizer formed from A1 disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 13 Hand Gel Sanitizer Formulation 1Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Thickener and Viscosity Polyethylene Glycol 0.01-0.1 Enhancer Guar gum 0.01-0.1 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 14 below shows a composition of a hand gel sanitizer formed from A1 disinfecting capsules and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 14 Hand Gel Sanitizer Formulation 2Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Polyhexamethylene 0.1 biguanide Stabilizer Polyvinyl alcohol 0.35 Thickener and Viscosity Polyethylene Glycol 0.01-0.1 Enhancer Guar gum 0.01-0.1 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 15 below shows a composition of a hand gel sanitizer formed from A1-thyme oil disinfecting capsules, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 15 Hand Gel Sanitizer Formulation 3Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Thyme oil 0.03 Thickener and Viscosity Polyethylene Glycol 0.01-0.1 Enhancer Guar gum 0.01-0.1 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 16 below shows a composition of a hand gel sanitizer formed from A1-thyme oil disinfecting capsules with lavender oil fragrance and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 16 Hand Gel Sanitizer Formulation 4Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Thyme oil 0.03 Fragrance Lavender oil 0.03 Thickener and Viscosity Polyethylene Glycol 0.01-0.1 Enhancer Guar gum 0.01-0.1 Fragrance Lavender oil 0.5 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 17 below shows a composition of a hand gel sanitizer formed from A1-thyme oil disinfecting capsules with lavender oil fragrance and vitamin E, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 17 Hand Gel Sanitizer Formulation 5Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Thyme oil 0.03 Fragrance Lavender oil 0.03 Skin-care Vitamin E 0.02 Thickener and Viscosity Polyethylene Glycol 0.01-0.1 Enhancer Guar gum 0.01-0.1 Fragrance Lavender oil 0.5 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 18 below shows a composition of a hand gel sanitizer comprising of A1-tea tree oil disinfecting capsules with lavender oil fragrance and eucalyptus oil, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 18 Hand Gel Sanitizer Formulation 6 Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Tea tree oil 0.03 Fragrance Lavender oil 0.03 Skin-care Eucalyptus oil 0.02 Thickener and Viscosity Polyethylene Glycol 0.01-0.1 Enhancer Guar gum 0.01-0.1 Fragrance Lavender oil 0.5 Moisturing and Wound Vitamin E ≤0.02 Healing Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - Table 19 below shows a composition of a hand gel sanitizer formed from D1-thyme oil disinfecting capsules with lavender oil fragrance and vitamin E, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension.
-
TABLE 19 Hand Gel Sanitizer Formulation 7 Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Polyhexamethylene 0.1 biguanide Stabilizer Polyvinyl alcohol 0.35 Disinfectant Thyme oil 0.03 Fragrance Lavender oil 0.03 Skin-care Vitamin E 0.02 Foam Stabilizer Tween ® 80 2.5 Foamer Sodium dodecyl sulfate 2.5 Moisturing and Wound Sodium hyaluronic ≤0.02 Healing Emollient Cetyl alcohol ≤0.02 Vitamin and Antioxidant Vitamin C ≤0.02 Freshness Handfeel Frescolat ® MGA ≤0.02 (Menthone Glycerin Acetal) - Table 20 below shows a composition of a hand gel sanitizer formed from D1-thyme oil disinfecting capsules with lavender oil fragrance and vitamin E, and was prepared by mixing the listed components in sequence to obtain a water-based colloidal suspension. The bactericidal tests were carried out on 105 CFU E. coli at 60 seconds contact.
-
TABLE 20 Hand Gel Sanitizer Formulation 8 Component Ingredient Weight Percent Antimicrobial Polymer Polyethylenimine 0.7 Stabilizer Polyvinyl alcohol 0.35 Disinfectant Cinnamaldehyde 0.03 (cinnamon) Thickener and Viscosity Glycerin 0.01-0.1 Enhancer Guar gum 0.01-0.1 Critic Acid ≤0.02 (pH adjustment to PH = 5.5 to 6.5) Water Balance to 100% - It is to be understood that the hand sanitizer and method of making the same is not limited to the specific embodiments described above, but encompasses any and all embodiments within the scope of the generic language of the following claims enabled by the embodiments described herein, or otherwise shown in the drawings or described above in terms sufficient to enable one of ordinary skill in the art to make and use the claimed subject matter.
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/994,140 US20230093881A1 (en) | 2019-07-22 | 2022-11-25 | Hand sanitizer and method of making the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/518,154 US11517510B2 (en) | 2019-07-22 | 2019-07-22 | Hand sanitizer and method of making the same |
US17/994,140 US20230093881A1 (en) | 2019-07-22 | 2022-11-25 | Hand sanitizer and method of making the same |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/518,154 Division US11517510B2 (en) | 2019-07-22 | 2019-07-22 | Hand sanitizer and method of making the same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230093881A1 true US20230093881A1 (en) | 2023-03-30 |
Family
ID=74189272
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/518,154 Active US11517510B2 (en) | 2019-07-22 | 2019-07-22 | Hand sanitizer and method of making the same |
US17/994,140 Pending US20230093881A1 (en) | 2019-07-22 | 2022-11-25 | Hand sanitizer and method of making the same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/518,154 Active US11517510B2 (en) | 2019-07-22 | 2019-07-22 | Hand sanitizer and method of making the same |
Country Status (1)
Country | Link |
---|---|
US (2) | US11517510B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11202010339YA (en) * | 2018-09-26 | 2020-11-27 | Firmenich & Cie | Powder detergent composition |
CN115350317B (en) * | 2022-08-30 | 2024-04-02 | 振德医疗用品股份有限公司 | Wound dressing composition and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7803746B2 (en) * | 2004-12-16 | 2010-09-28 | Georgia-Pacific Consumer Products Lp | Antimicrobial foam hand soap comprising inulin or an inulin surfactant |
US7838477B2 (en) * | 2006-08-24 | 2010-11-23 | Kimberly-Clark Worldwide, Inc. | Liquid cleanser formulation with suspending and foaming capabilities |
KR102195307B1 (en) * | 2016-06-30 | 2020-12-28 | 더 홍콩 유니버시티 오브 사이언스 앤드 테크놀러지 | Colloidal antibacterial and anti-bioadhesive coating on the surface |
-
2019
- 2019-07-22 US US16/518,154 patent/US11517510B2/en active Active
-
2022
- 2022-11-25 US US17/994,140 patent/US20230093881A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20210022969A1 (en) | 2021-01-28 |
US11517510B2 (en) | 2022-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230093881A1 (en) | Hand sanitizer and method of making the same | |
TWI498423B (en) | Antimicrobial compositions | |
CA2151774C (en) | Skin disinfecting formulations | |
US5716611A (en) | Emollient antimicrobial formulations containing povidone iodine | |
US5403587A (en) | Disinfectant and sanitizing compositions based on essential oils | |
US6846498B2 (en) | Antimicrobial composition formulated with essential oils | |
KR101529308B1 (en) | Composition and method for pre-surgical skin disinfection | |
EP1830636B1 (en) | Pumped foam containing alcohol | |
KR101555341B1 (en) | Antibiotic wet tissue, and manufacturing method thereof | |
US20090035339A1 (en) | Methods of Inactivating Viruses | |
US8741271B2 (en) | Antimicrobial compositions containing essential oils | |
CN109381480A (en) | Compound poly hexamethylene biguanide thimerosal and preparation method thereof | |
EP1581052A2 (en) | An emollient alcohol skin disinfecting formulation | |
JP2014224160A (en) | Sporicidal hand sanitizing composition and method of producing the same | |
WO2004000016A9 (en) | Antimicrobial compositions, products and methods employing same | |
US8147877B2 (en) | Essential oils based disinfecting compositions having tuberculocidal and fungicidal efficacies | |
US20140030203A1 (en) | Antimicrobial compositions containing essential oils | |
CN104382807A (en) | Alcohol-free washing-free antibacterial hand sanitizer and preparation method thereof | |
US20170055523A1 (en) | Emulsion disinfecting, sanitizing, and cleaning compositions made with antimicrobial agents | |
WO2020167933A1 (en) | Alcohol-free hydrogen peroxide disinfectant compositions and methods of use thereof | |
CN113423469A (en) | Topical disinfectant compositions | |
US20020123440A1 (en) | Foamable antimicrobial formulation | |
WO2019174867A1 (en) | A sanitizer composition | |
US11304416B2 (en) | Cyclopentasiloxane and cationic biocide as a formulation additive to enhance persistent sanitizing and miscibility | |
WO1993017723A1 (en) | Biodegradable surface disinfectant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: GERMAGIC BIOCHEMICAL TECHNOLOGY (SHANGHAI) CO., LTD., CHINA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YEUNG, KING LUN;LI, YING;ZHAN, NING;SIGNING DATES FROM 20190910 TO 20190926;REEL/FRAME:061888/0498 Owner name: CHIAPHUA INDUSTRIES LIMITED, CHINA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YEUNG, KING LUN;LI, YING;ZHAN, NING;SIGNING DATES FROM 20190910 TO 20190926;REEL/FRAME:061888/0498 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |